Living with the thick, scaly patches of plaque psoriasis can be a daily struggle. A new study tested whether a pill called ME3183 could offer relief. In a trial of 132 people with moderate to severe psoriasis, more patients who took ME3183 saw their skin plaques clear significantly compared to those who got a placebo. The results varied by dose, but the best results showed over 60% of patients on the drug had a major improvement, versus about 15% on the placebo.
The trial was designed to be a fair test—it was randomized and double-blind, meaning neither patients nor doctors knew who was getting the real drug. This gives us more confidence that the drug itself was responsible for the improvement. The study lasted 16 weeks, which is a common timeframe to see if a psoriasis treatment starts working.
It's important to know that this promising result came with common side effects. People taking ME3183 frequently reported diarrhea, nausea, and headaches. The study didn't report on more serious side effects or how many people had to stop the drug because of these issues. The researchers themselves say these findings mean ME3183 'should be further investigated'—it's not ready for doctors to prescribe yet. This was a relatively small study, a necessary first look to see if the drug is worth pursuing in larger, longer trials.